Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care

Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials

(2015) Giulia Renda et al.   AMERICAN JOURNAL OF MEDICINE

Anticoagulant-related gastrointestinal bleeding—could this facilitate early detection of benign or malignant gastrointestinal lesions?

(2014) Andreas Clemens et al.   ANNALS OF MEDICINE

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

(2014) J. Beyer-Westendorf et al.   BLOOD

Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care - results from the Dresden NOAC registry

(2014) Jan Beyer-Westendorf et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

(2014) François Laliberté et al.   CURRENT MEDICAL RESEARCH AND OPINION

The Danish Civil Registration System as a tool in epidemiology

(2014) Morten Schmidt et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation

(2014) Torben Larsen et al.   THROMBOSIS AND HAEMOSTASIS

New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis

(2013) I. Lisanne Holster et al.   GASTROENTEROLOGY

Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation

(2013) Torben Bjerregaard Larsen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A tutorial on propensity score estimation for multiple treatments using generalized boosted models

(2013) Daniel F. McCaffrey et al.   STATISTICS IN MEDICINE

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

(2012) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data

(2012) Alan R. Ellis et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples

(2011) Jeremy A. Rassen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development

(2011) S Schneeweiss et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Danish National Prescription Registry

(2011) Helle Wallach Kildemoes et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

The Danish National Patient Register

(2011) Elsebeth Lynge et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Invited Commentary: Positivity in Practice

(2010) D. Westreich et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution--A Simulation Study

(2010) T. Sturmer et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE